| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |